$43.45
0.59% today
NYSE, Sep 03, 05:13 pm CET

CryoLife Stock price

$43.71
+11.65 36.34% 1M
+18.58 73.94% 6M
+15.12 52.89% YTD
+16.57 61.05% 1Y
+22.98 110.85% 3Y
+23.49 116.17% 5Y
+33.85 343.31% 10Y
+35.88 458.24% 20Y
NYSE, Closing price Tue, Sep 02 2025
-0.22 0.50%

Key metrics

Basic
Market capitalization
$2.1b
Enterprise Value
$2.2b
Net debt
$165.9m
Cash
$53.5m
Shares outstanding
47.1m
Valuation (TTM | estimate)
P/E
negative | 378.8
P/S
5.1 | 4.6
EV/Sales
5.5 | 5.0
EV/FCF
290.9
P/B
4.9
Dividends
DPS
$0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | 0.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$405.0m | $446.8m
EBITDA
$36.3m | $88.3m
EBIT
$21.0m | $29.9m
Net Income
$-17.9m | $5.4m
Free Cash Flow
$7.7m
Growth (TTM | estimate)
Revenue
7.5% | 15.0%
EBITDA
-15.6% | 59.4%
EBIT
-23.0% | -23.1%
Net Income
-115.1% | 140.8%
Free Cash Flow
-16.7%
Margin (TTM | estimate)
Gross
64.0%
EBITDA
9.0% | 19.8%
EBIT
5.2%
Net
-4.4% | 1.2%
Free Cash Flow
1.9%
Financial Health
Equity Ratio
35.0%
Return on Equity
-4.8%
ROCE
2.7%
ROIC
3.0%
Debt/Equity
0.5
More
EPS
$-0.4
FCF per Share
$0.2
Short interest
2.6%
Employees
2k
Rev per Employee
$240.0k
Show more

Is CryoLife a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

CryoLife Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a CryoLife forecast:

12x Buy
92%
1x Hold
8%

Analyst Opinions

13 Analysts have issued a CryoLife forecast:

Buy
92%
Hold
8%

Financial data from CryoLife

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
405 405
7% 7%
100%
- Direct Costs 146 146
9% 9%
36%
259 259
6% 6%
64%
- Selling and Administrative Expenses 195 195
13% 13%
48%
- Research and Development Expense 28 28
2% 2%
7%
36 36
16% 16%
9%
- Depreciation and Amortization 15 15
3% 3%
4%
EBIT (Operating Income) EBIT 21 21
23% 23%
5%
Net Profit -18 -18
115% 115%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about CryoLife directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoLife Stock News

Positive
Seeking Alpha
about 4 hours ago
Artivion continues to outperform with double-digit revenue growth, strong clinical results, and share gains in niche cardiology markets despite a challenging med-tech environment. New products like AMDS, Nexus, and Arcevo, along with mechanical heart valve growth, underpin a robust outlook and potential for further upside. Clinical and regulatory wins, including FDA approvals and strong study r...
Neutral
Seeking Alpha
26 days ago
Artivion, Inc. (NYSE:AORT ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Lance A. Berry - Executive VP of Finance & CFO Pat MacKin - Corporate Participant Conference Call Participants Daniel Walker Stauder - Citizens JMP Securities, LLC, Research Division Destiny Alexandra Hance Buch - Ladenburg Thalmann & Co. Inc., Research Division John Glenn McAulay - Stife...
Positive
The Motley Fool
27 days ago
Artivion (AORT) Q2 EPS Jumps 243%
More CryoLife News

Company Profile

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the following segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PerClot and PhotoFix. The Preservation Services segment focuses on external services revenues from the preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Head office United States
CEO James Mackin
Employees 1,600
Founded 1984
Website artivion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today